HOPA introduces BCOP Sprint, new education programming where you can earn BCOP CEs and take a deep dive into the latest developments in hem/onc pharmacy - all in just 30 minutes.
"UnPACCing Treatment of Uncommon EGFR Mutations"
This presentation will provide an overview of uncommon EGFR mutations in non-small cell lung cancer, focusing on PACC mutations. We will review a structure-based classification framework for EGFR mutations and how this influences drug binding, treatment sensitivity, and therapeutic decision making. Participants will review current guidelines as well as emerging clinical evidence for the first line treatment of EGFR PACC mutations, including novel agents. Real world data, clinical trial data, and a case example will be used to highlight practical considerations in treatment selection and unmet needs in this patient population.
Membership
JoinBenefitsRenew Your Membership
Privacy & Terms
About UsCode of Conduct